ProShares Russell 2000 High Income ETF
ITWO - ETF AI Analysis
Top Page
ProShares Russell 2000 High Income ETF (ITWO)
ITWO, the ProShares Russell 2000 High Income ETF, has a solid overall rating driven mainly by strong, diversified holdings like CareTrust REIT, UMB Financial, Moog, JFrog, and Jackson Financial, which show healthy revenue growth, strategic expansion, and supportive technical trends. However, several holdings such as Glaukos, BrightSpring Health Services, ViaSat, and TG Therapeutics face profitability, leverage, or momentum challenges that limit the fund’s upside. The main risk factor is exposure to multiple companies with high leverage, overbought technical signals, or weak current profitability, which can increase volatility even as the fund benefits from generally positive growth and earnings trends.
ITWO vs. SPDR S&P 500 ETF (SPY)
- AUM
- 172.66M
- Region
- North America
- Expense Ratio
- 0.55%
- Beta
- 0.91
- Issuer
- ProShares
- Inception Date
- Sep 04, 2024
- Dividend Yield
- 8.51%
- Asset Class
- Equity
- Index Tracked
- Cboe Russell 2000 Daily Covered Call Index - Benchmark TR Gross
ITWO Summary
The ProShares Russell 2000 High Income ETF (ITWO) invests in smaller U.S. companies and follows the Russell 2000 High Dividend Index, focusing on small-cap stocks that pay relatively high dividends. It holds a wide mix of businesses across health care, financials, technology, and more, including names like JFrog and SM Energy. Someone might consider this ETF to seek both income from dividends and potential growth from smaller, fast-moving companies, while getting diversification across many stocks. A key risk is that small-cap stocks can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.55%, which means you’ll pay about $5.50 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because this fund uses a more specialized, income-focused strategy rather than plain passive market tracking.
What would affect this ETF?
This ETF focuses on U.S. small-cap companies with high dividend income, so it could benefit if the U.S. economy grows steadily, interest rates eventually ease, and sectors like health care, financials, technology, and energy perform well. On the downside, small caps can be hit harder by economic slowdowns, higher-for-longer interest rates, tighter credit conditions, or sector-specific issues in areas like health care and financials, which could hurt both stock prices and dividend payouts.
ITWO Top 10 Holdings
ITWO is powered by a quirky mix of small-cap health care, tech, and energy names, all U.S.-based. Glaukos and 10x Genomics have been rising stars, giving the fund a lift as investors warm to innovative medical and life-science plays. SM Energy and Brinker International add some steady, cash-generating muscle, helping balance out the more volatile growth names. On the softer side, Twist Bioscience has been mixed and losing steam lately, while Moog and UMB Financial have been more subdued, keeping overall performance in check rather than turbocharged.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Glaukos | 0.46% | $772.40K | $14.09B | 149.28% | 61Neutral | |
| JFrog | 0.40% | $670.92K | $13.62B | 70.41% | 73Outperform | |
| Bright Horizon Energy | 0.36% | $611.60K | $48.81M | 12.20% | 74Outperform | |
| BrightSpring Health Services, Inc. | 0.36% | $605.25K | $12.74B | 91.82% | 67Neutral | |
| UMB Financial | 0.32% | $535.41K | $9.79B | 21.20% | 77Outperform | |
| TG Therapeutics | 0.31% | $531.30K | $9.81B | 108.01% | 65Neutral | |
| Moog | 0.31% | $527.86K | $10.39B | 68.44% | 73Outperform | |
| Ryman | 0.30% | $509.61K | $9.21B | 47.10% | 66Neutral | |
| CareTrust REIT | 0.30% | $500.99K | $9.54B | 1.49% | 80Outperform | |
| Jackson Financial Incorporation | 0.29% | $482.22K | $8.56B | 38.44% | 73Outperform |
ITWO Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ITWO, the sentiment is Negative. The current price of 39.26 is below the 20-day moving average (MA) of 42.45, below the 50-day MA of 42.69, and below the 200-day MA of 42.52, indicating a bearish trend. The MACD of -0.61 indicates Positive momentum. The RSI at 29.52 is Positive, neither overbought nor oversold. The STOCH value of 6.71 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ITWO.
ITWO Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $39.26 | $44.00(12.07% Upside) | $172.66M | 0.55% | 58Neutral | |
| $36.27 | $47.49(30.95% Upside) | $902.31M | 0.49% | 68Neutral | |
| $47.02 | $53.77(14.35% Upside) | $810.00M | 0.48% | 72Outperform | |
| $79.33 | $106.57(34.33% Upside) | $705.70M | 0.09% | 63Neutral | |
| $44.73 | $55.86(24.86% Upside) | $675.58M | 0.42% | 67Neutral | |
| $61.53 | $80.70(31.15% Upside) | $652.44M | 0.38% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ITWO | ProShares Russell 2000 High Income ETF | 39.26 | 3.34 | 9.31% | |
| SFLO | VictoryShares Small Cap Free Cash Flow ETF | 36.27 | 8.12 | 28.86% | |
| OUSM | OShares U.S. Small-Cap Quality Dividend ETF | 47.02 | 4.95 | 11.76% | |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 79.33 | 7.33 | 10.18% | |
| JHSC | John Hancock Multifactor Small Cap ETF | 44.73 | 4.01 | 9.85% | |
| EES | WisdomTree U.S. SmallCap Fund | 61.53 | 7.50 | 13.87% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
